Related Experiment Video
Updated: Aug 29, 2026

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
Published on: July 14, 2020
Role of mannan-binding protein, MBP, in innate immunity
Tomoaki Nakagawa1, Bruce Yong Ma, Kazuhide Uemura
1Department of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Abstract:
Mannan-binding protein (MBP) is a C-type lectin, which binds to carbohydrates on the surface of some microorganisms and kills them through the activation of complement. This complement activation pathway is called the lectin pathway. MBP also kills mammalian cells that express MBP ligands on their surfaces via the lectin pathway. Recently, we found anti-tumor activity of MBP in vivo using tumor cells transplanted into nude mice. We propose to call this anti-tumor effect mannan-binding protein-dependent cell-mediated cytotoxicity (MDCC), because it does not require complement activation, and the involvement of some immune cells was assumed. Very recently, MBP was demonstrated to be selectively expressed in epithelial cells of the small intestine. This finding may suggest that MBP plays an important role in the small intestine as a host defense factor.
Insights
Mannan-binding protein (MBP) exhibits anti-tumor effects through a novel mechanism called mannan-binding protein-dependent cell-mediated cytotoxicity (MDCC). This process involves immune cells and does not require complement activation, suggesting a new therapeutic avenue.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Mannan-binding protein (MBP) is a C-type lectin involved in innate immunity by activating the complement system.
- MBP binds to carbohydrate structures on microorganisms, facilitating their clearance.
- MBP also interacts with mammalian cells expressing specific ligands.
Purpose of the Study:
- To investigate the potential anti-tumor activity of MBP.
- To characterize the mechanism of MBP-mediated tumor cell killing.
- To explore the role of MBP in host defense within the small intestine.
Main Methods:
- In vivo studies using tumor cells transplanted into nude mice.
- Observation and characterization of MBP's effect on tumor growth.
- Analysis of the mechanism, distinguishing it from complement-dependent pathways.
Main Results:
- MBP demonstrated significant anti-tumor activity in vivo.
- A novel cytotoxic mechanism, termed mannan-binding protein-dependent cell-mediated cytotoxicity (MDCC), was identified.
- MDCC does not rely on complement activation and involves immune cells.
- MBP is selectively expressed in small intestine epithelial cells, suggesting a role in host defense.
Conclusions:
- MBP possesses inherent anti-tumor properties mediated by a novel cytotoxic pathway (MDCC).
- MDCC represents a complement-independent mechanism involving immune cells, offering potential for cancer therapy.
- The selective expression of MBP in the small intestine highlights its importance as a host defense factor in this organ.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Meningitis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Blood-brain Barrier
Bacterial Meningitis II: Pathophysiology

